Category: Include on Menu
-

Quoin Pharmaceuticals stock skyrockets after meeting rapamycin formulation goals
Shares of Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) surged 66% in premarket trading Tuesday after the biopharmaceutical company announced it had successfully achieved its target loading concentrations for two of its topical rapamycin delivery platforms. The late-stage specialty pharma firm said it reached a 4% w/w rapamycin concentration for its proprietary topical cream and an even higher…
-

Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Stocks Ease as Markets Consolidate Gains Ahead of Government Reopening
U.S. equities traded mostly lower on Tuesday, as investors consolidated positions following a strong rally in technology shares, while optimism grew that the longest government shutdown in U.S. history was finally nearing its end. At 09:35 ET, the Dow Jones Industrial Average rose 80 points (0.2%), while the S&P 500 dipped 10 points (0.2%), and…
-

Allurion Shares Jump 10.9% After FDA Progress and Debt Exchange Deal
Allurion Technologies Inc. (NYSE:ALUR) shares soared 10.9% in premarket trading Tuesday after the metabolic health company announced major progress in its U.S. regulatory process and a debt exchange agreement that would eliminate all of its outstanding debt. The company said it has achieved key milestones in the FDA Pre-Market Approval (PMA) process for its Allurion…
-

Parker-Hannifin Shares Drop After Announcing $9.25 Billion Acquisition of Filtration Group
Parker-Hannifin Corporation (NYSE:PH) shares fell 2.9% in premarket trading Tuesday after the company unveiled plans to acquire Filtration Group Corporation for $9.25 billion in cash, marking one of its largest deals to date. The transaction, which remains subject to regulatory approval, is expected to close within six to twelve months. Parker said it will finance…
-

Turbo Energy Shares Jump 12.5% After Announcing Blockchain-Based Renewable Energy Project
Turbo Energy S.A. ADR (NASDAQ:TURB) shares surged 12.5% in premarket trading Tuesday after the Spanish solar energy storage company unveiled a blockchain-powered project to tokenize financing for hybrid renewable energy systems. The initiative is being launched in partnership with Taurus S.A., a leader in blockchain infrastructure, and the Stellar Development Foundation. The project will begin…
-

POET Technologies Shares Climb on New AI-Focused Partnership with QCi
POET Technologies Inc. (NASDAQ:POET) shares rose 2.3% in premarket trading Tuesday after the company announced a strategic collaboration with Quantum Computing Inc. (NASDAQ:QUBT) to jointly develop next-generation optical engines designed to power high-speed AI network infrastructure. The partnership will focus on creating 400G/Lane thin-film lithium niobate (TFLN) modulator-based 3.2Tbps optical engines, which would double the…
-

INOVIO Shares Drop 10% After Discounted $25 Million Public Offering
INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% in early trading after the biotech company announced the pricing of a $25 million underwritten public offering at $1.90 per share, a discount compared to Monday’s closing price of $2.15. The offering includes 13,158,000 shares of common stock, all of which will be sold by INOVIO. The company…
-

Constellation Energy Among Top Utilities Set to Benefit from U.S. Nuclear Expansion, Says BofA
Constellation Energy (NASDAQ:CEG) and several major U.S. utilities are expected to be key beneficiaries of a new federal initiative to accelerate nuclear power development, according to analysts at BofA Securities. The U.S. government recently announced a strategic partnership with Westinghouse and Cameco aimed at building a new wave of nuclear generation facilities. Early reports indicate…
-

Endava Shares Plunge Over 14% After Weak Q1 Results and Soft Guidance
Endava plc (NYSE:DAVA) shares sank more than 14% in premarket trading Tuesday after the IT services and digital transformation company posted disappointing fiscal first-quarter 2026 results and issued a downbeat outlook for the rest of the year. The company reported earnings of £0.15 per share, missing analyst expectations of £0.18, while revenue came in at…
-

enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates
enGene Holdings Inc. (NASDAQ:ENGN) shares climbed 5% on Tuesday after the clinical-stage genetic medicines company reported promising new data showing improved complete response rates for its investigational bladder cancer treatment detalimogene voraplasmid. The company said that detalimogene achieved a 62% complete response rate at six months in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer…